Premium Nahrungsergänzungsmittel | artgerecht

Adiponectin – Hormone, Function and Significance

Adiponectin is a hormone produced by fat tissue that regulates metabolism and provides protective effects on the heart and blood vessels.

Regular tips about health Regular tips about health

Things worth knowing about "Adiponectin"

Adiponectin is a hormone produced by fat tissue that regulates metabolism and provides protective effects on the heart and blood vessels.

What is Adiponectin?

Adiponectin is a protein hormone secreted primarily by white adipose tissue cells (adipocytes) into the bloodstream. It belongs to a group of signaling molecules called adipokines – substances produced and released by fat tissue. Adiponectin plays a key role in regulating energy metabolism, insulin sensitivity, and inflammatory processes throughout the body.

Biological Functions

Adiponectin exerts its effects through specific receptors (AdipoR1 and AdipoR2) found in various tissues, particularly skeletal muscle, liver, and heart. Its main biological actions include:

Improving insulin sensitivity: Adiponectin enhances the response of body cells to insulin, helping to lower blood glucose levels.
Promoting fat burning: It activates fatty acid oxidation in muscles and the liver.
Anti-inflammatory effects: Adiponectin suppresses pro-inflammatory cytokines, protecting against chronic inflammation.
Cardiovascular protection: It inhibits the adhesion of foam cells to vessel walls, thereby reducing the risk of atherosclerosis.
Protection against non-alcoholic fatty liver disease: Adiponectin reduces fat accumulation in the liver and dampens hepatic inflammation.

Adiponectin and Obesity

Paradoxically, blood levels of adiponectin decrease as body fat increases – even though fat cells are the main producers of this hormone. Adiponectin levels are especially low in individuals with visceral obesity (excess abdominal fat). This reduction is closely linked to an elevated risk of type 2 diabetes, metabolic syndrome, cardiovascular disease, and non-alcoholic fatty liver disease.

Clinical Relevance – Associated Conditions

Low adiponectin levels have been associated with a number of health conditions:

Type 2 diabetes mellitus: Reduced adiponectin contributes to insulin resistance.
Metabolic syndrome: A cluster of conditions including obesity, high blood pressure, elevated blood lipids, and impaired glucose tolerance.
Coronary artery disease and atherosclerosis: Due to reduced vascular protective effects.
Non-alcoholic steatohepatitis (NASH): An inflammatory form of fatty liver disease.
Certain cancers: Low adiponectin levels have been associated with an increased risk of colorectal and breast cancer in observational studies.

Measurement and Diagnostics

Adiponectin can be measured in blood serum. Normal concentrations tend to be higher in women than in men. Reference ranges may vary depending on the laboratory and assay method used. While not yet a standard part of routine clinical testing, adiponectin measurement is widely used in research settings and may be used in specialized metabolic clinics for risk stratification.

Factors Influencing Adiponectin Levels

Several lifestyle and pharmacological factors can affect adiponectin production and blood concentration:

Body weight: Weight loss is consistently associated with an increase in adiponectin levels.
Physical activity: Regular aerobic exercise stimulates adiponectin secretion.
Diet: A Mediterranean-style diet, as well as consumption of omega-3 fatty acids, dietary fiber, and certain plant-derived compounds (e.g., resveratrol), may positively influence adiponectin levels.
Medications: Certain antidiabetic drugs – particularly thiazolidinediones such as pioglitazone – are known to significantly raise adiponectin levels.
Sex and age: Women generally have higher adiponectin levels than men; levels may decline with advancing age.

Therapeutic Perspectives

Due to its wide-ranging protective effects, adiponectin is considered a promising therapeutic target for metabolic diseases. Adiponectin receptor agonists – compounds that mimic or enhance adiponectin signaling (such as AdipoRon) – are currently being investigated in preclinical and early clinical research. Pharmacologically increasing adiponectin activity may become a future treatment strategy for type 2 diabetes, atherosclerosis, and other metabolic disorders.

References

Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews, 2005; 26(3): 439–451. PubMed PMID: 15897298.
Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta, 2007; 380(1–2): 24–30. PubMed PMID: 17316581.
World Health Organization (WHO). Obesity and overweight – Key facts. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed 2024).

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.